Advertisement

Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens

  • E. Kousouli
  • O. Zarkotou
  • L. Politi
  • K. Polimeri
  • G. Vrioni
  • K. Themeli-Digalaki
  • A. Tsakris
  • S. Pournaras
Original Article

Abstract

We evaluated an infection control (IC) program influenced by personnel and material resource shortages on the incidence of bloodstream infections (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPA) in an endemic region. Between January 2010 and December 2015, all BSI episodes caused by CRKP, CRAB, and CRPA were recorded. An IC bundle was implemented in January 2012. We evaluated the effect of the interventions on BSI rates between the pre-intervention (2010–2011) and intervention (2012–2013) periods, using an interrupted time-series model. From 2014, when interventions were still applied, BSI incidence was gradually increased. For this reason, we evaluated with a linear mixed effects model several factors possibly contributing to this increase for the years 2012–2015, which was considered as the intervention/follow-up period. During the study period, 351 patients with BSI were recorded, with a total of 538 episodes; the majority (83.6%) occurred in the intensive care unit (ICU). The BSI incidence rate per year during 2010–2015 for ICU patients was 21.03/19.63/17.32/14.45/22.85/25.02 per 1000 patient-days, respectively, with the reduction in BSI levels after the start of intervention marginal (p = 0.054). During the follow-up period (2014–2015), the most influential factors for the increased BSI incidence were the reduced participation in educational courses and compliance with hand hygiene. The implementation of IC interventions reduced the BSI incidence rates, particularly for ICU patients. However, factors possibly related to the restrictions of human and material resources apparently contributed to the observed expansion of BSI in our endemic setting.

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

All authors report no conflicts of interest relevant to this article.

Ethical approval

The study was approved by the Ethics Committee of Tzaneio Hospital.

Informed consent

Not required.

References

  1. 1.
    European Centre for Disease Prevention and Control (ECDC) (2017) Antimicrobial resistance surveillance in Europe 2015. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-net). ECDC, Stockholm.  https://doi.org/10.2900/6928
  2. 2.
    Cerceo E, Deitelzweig SB, Sherman BM, Amin AN (2016) Multidrug-resistant Gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist 22:412–431.  https://doi.org/10.1089/mdr.2015.0220 CrossRefPubMedGoogle Scholar
  3. 3.
    Mitharwal SM, Yaddanapudi S, Bhardwaj N, Gautam V, Biswal M, Yaddanapudi L (2016) Intensive care unit-acquired infections in a tertiary care hospital: an epidemiologic survey and influence on patient outcomes. Am J Infect Control 44:e113–e117.  https://doi.org/10.1016/j.ajic.2016.01.021 CrossRefPubMedGoogle Scholar
  4. 4.
    Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U et al (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20(Suppl 1):1–55.  https://doi.org/10.1111/1469-0691.12427 CrossRefPubMedGoogle Scholar
  5. 5.
    European Centre for Disease Prevention and Control (ECDC) (2014) Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients. ECDC, Stockholm.  https://doi.org/10.2900/418192
  6. 6.
    Wilson AP, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA et al (2016) Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect 92(Suppl 1):S1–S44.  https://doi.org/10.1016/j.jhin.2015.08.007 CrossRefPubMedGoogle Scholar
  7. 7.
    Munoz-Price LS, Quinn JP (2013) Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis 26:378–387.  https://doi.org/10.1097/01.qco.0000431853.71500.77 CrossRefPubMedGoogle Scholar
  8. 8.
    Viale P, Tumietto F, Giannella M, Bartoletti M, Tedeschi S, Ambretti S et al (2015) Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin Microbiol Infect 21:242–247.  https://doi.org/10.1016/j.cmi.2014.10.020 CrossRefPubMedGoogle Scholar
  9. 9.
    Enfield KB, Huq NN, Gosseling MF, Low DJ, Hazen KC, Toney DM et al (2014) Control of simultaneous outbreaks of carbapenemase-producing Enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit. Infect Control Hosp Epidemiol 35:810–817.  https://doi.org/10.1086/676857 CrossRefPubMedGoogle Scholar
  10. 10.
    Crivaro V, Di Popolo A, Caprio A, Lambiase A, Di Resta M, Borriello T et al (2009) Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. BMC Infect Dis 9:70.  https://doi.org/10.1186/1471-2334-9-70 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Otter JA, Mutters NT, Tacconelli E, Gikas A, Holmes AH (2015) Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. Clin Microbiol Infect 21:1057–1066.  https://doi.org/10.1016/j.cmi.2015.09.021 CrossRefPubMedGoogle Scholar
  12. 12.
    Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y (2015) Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect 21:30–34.  https://doi.org/10.1016/j.cmi.2014.08.001 CrossRefPubMedGoogle Scholar
  13. 13.
    Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group (2015) Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 20(45).  https://doi.org/10.2807/1560-7917.ES.2015.20.45.30062
  14. 14.
    Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT et al; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group (2017) Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 17(2):153–163.  https://doi.org/10.1016/S1473-3099(16)30257-2
  15. 15.
    Mutters NT, Günther F, Frank U, Mischnik A (2016) Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures. J Hosp Infect 93:191–196.  https://doi.org/10.1016/j.jhin.2016.02.013 CrossRefPubMedGoogle Scholar
  16. 16.
    Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L et al (2015) Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis 15:212–224.  https://doi.org/10.1016/S1473-3099(14)70854-0 CrossRefPubMedGoogle Scholar
  17. 17.
    Rodríguez-Baño J, del Toro MD, López-Méndez J, Mutters NT, Pascual A (2015) Minimum requirements in infection control. Clin Microbiol Infect 21:1072–1076.  https://doi.org/10.1016/j.cmi.2015.08.025 CrossRefPubMedGoogle Scholar
  18. 18.
    Organisation for Economic Co-operation and Development (OECD) (2015) Health at a glance 2015: OECD indicators. OECD Publishing, Paris.  https://doi.org/10.1787/health_glance-2015-en. Accessed 28 Feb 2016Google Scholar
  19. 19.
    van Gool K, Pearson M (2014) Health, austerity and economic crisis: assessing the short-term impact in OECD countries. OECD Health Working Papers, no. 76, OECD Publishing.  https://doi.org/10.1787/5jxx71lt1zg6-en. Accessed 1 Mar 2016
  20. 20.
    Simou E, Koutsogeorgou E (2014) Effects of the economic crisis on health and healthcare in Greece in the literature from 2009 to 2013: a systematic review. Health Policy 115:111–119.  https://doi.org/10.1016/j.healthpol.2014.02.002 CrossRefPubMedGoogle Scholar
  21. 21.
    Centers for Disease Control and Prevention (CDC) (2016) Identifying healthcare-associated infections (HAI) for NHSN surveillance. January 2016. CDCGoogle Scholar
  22. 22.
    Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K et al (2010) A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother 65:1664–1671.  https://doi.org/10.1093/jac/dkq210 CrossRefPubMedGoogle Scholar
  23. 23.
    Pournaras S, Zarkotou O, Poulou A, Kristo I, Vrioni G, Themeli-Digalaki K et al (2013) A combined disk test for direct differentiation of carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs. J Clin Microbiol 51:2986–2990.  https://doi.org/10.1128/JCM.00901-13 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    European Centre for Disease Prevention and Control (ECDC) (2011) Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. ECDC, Stockholm.  https://doi.org/10.2900/59034
  25. 25.
    Birgand G, Moore LS, Bourigault C, Vella V, Lepelletier D, Holmes AH et al (2016) Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost? Clin Microbiol Infect 22:162.e1–162.e9.  https://doi.org/10.1016/j.cmi.2015.10.001 CrossRefGoogle Scholar
  26. 26.
    Maresso A, Mladovsky P, Thomson S, Sagan A, Karanikolos M, Richardson E et al (2015) Economic crisis, health systems and health in Europe: country experience. WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen. http://www.euro.who.int/__data/assets/pdf_file/0010/279820/Web-economic-crisis-health-systems-and-health-web.pdf?ua=1. Accessed 10 Mar 2016Google Scholar
  27. 27.
    Rachiotis G, Kourousis C, Kamilaraki M, Symvoulakis EK, Dounias G, Hadjichristodoulou C (2014) Medical supplies shortages and burnout among Greek health care workers during economic crisis: a pilot study. Int J Med Sci 11:442–447.  https://doi.org/10.7150/ijms.7933 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Cimiotti JP, Aiken LH, Sloane DM, Wu ES (2012) Nurse staffing, burnout, and health care-associated infection. Am J Infect Control 40:486–490.  https://doi.org/10.1016/j.ajic.2012.02.029 CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Valentin A, Ferdinande P; ESICM Working Group on Quality Improvement (2011) Recommendations on basic requirements for intensive care units: structural and organizational aspects. Intensive Care Med 37:1575–1587.  https://doi.org/10.1007/s00134-011-2300-7 CrossRefPubMedGoogle Scholar
  30. 30.
    Goto M, O’Shea AM, Livorsi DJ, McDanel JS, Jones MM, Richardson KK et al (2016) The effect of a nationwide infection control program expansion on hospital-onset Gram-negative rod bacteremia in 130 veterans health administration medical centers: an interrupted time-series analysis. Clin Infect Dis 63:642–650.  https://doi.org/10.1093/cid/ciw423 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • E. Kousouli
    • 1
  • O. Zarkotou
    • 1
    • 2
  • L. Politi
    • 3
  • K. Polimeri
    • 1
  • G. Vrioni
    • 3
  • K. Themeli-Digalaki
    • 1
    • 2
  • A. Tsakris
    • 3
  • S. Pournaras
    • 3
    • 4
  1. 1.Infection Control CommitteeTzaneio General HospitalPiraeusGreece
  2. 2.Department of Clinical MicrobiologyTzaneio General HospitalPiraeusGreece
  3. 3.Department of MicrobiologyNational and Kapodistrian University of AthensAthensGreece
  4. 4.Laboratory of Clinical Microbiology, ATTIKON HospitalNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations